Csaba Kerepesi,
Hassan Mohammed Abushukair,
Biagio Ricciuti,
Amin H Nassar,
Elio Adib,
Joao V Alessi
et al.:
Association of Baseline Tumor-Specific Neoantigens and CD8+ T-Cell Infiltration With Immune-Related Adverse Events Secondary to Immune Checkpoint Inhibitors
JCO Precision Oncology (JCO PO) 2024
DOI
Erna-Elise Paulsen,
Sigve Andersen,
Mehrdad Rakaee,
Mona Irene Pedersen,
Ana Paola Lombardi,
Mette Pøhl
et al.:
Impact of microvessel patterns and immune status in NSCLC: a non-angiogenic vasculature is an independent negative prognostic factor in lung adenocarcinoma
Mehrdad Rakaee,
Sigve Andersen,
K. Giannikou,
Erna-Elise Paulsen,
Thomas Karsten Kilvær,
Lill-Tove Rasmussen Busund
et al.:
Machine learning-based immune phenotypes correlate with STK11/KEAP1 co-mutations and prognosis in resectable NSCLC: a sub-study of the TNM-I trial
Lorenzo Nibid,
Carlo Greco,
Ermanno Cordelli,
Giovanna Sabarese,
Michele Fiore,
Charles Z. Liu
et al.:
Deep pathomics: A new image-based tool for predicting response to treatment in stage III non-small cell lung cancer
Biagio Ricciuti,
Arielle Elkrief,
Joao Alessi,
Xinan Wang,
Yvonne Li,
Hersh Gupta
et al.:
Clinicopathologic, Genomic, and Immunophenotypic Landscape of ATM Mutations in Non–Small Cell Lung Cancer
Clinical Cancer Research 2023
DOI
Donjeta Gjuka,
Elio Adib,
Kendra Garrison,
Jianfeng Chen,
Yuxue Zhang,
Wenjiao Li
et al.:
Enzyme-mediated depletion of methylthioadenosine restores T cell function in MTAP-deficient tumors and reverses immunotherapy resistance
Cancer Cell 28. September 2023
DOI
Mehrdad Rakaee,
Elio Adib,
Biagio Ricciuti,
Lynette M. Sholl Sholl,
Weiwei Shi,
Joao V. Alessi
et al.:
Association of machine learning-based assessment of tumor-infiltrating lymphocytes on standard histologic images with outcomes of immunotherapy in patients with NSCLC
JAMA Oncology 17. November 2022
DOI
Håkon Andre Ramberg,
Elin Richardsen,
Gustavo Antonio De Souza,
Mehrdad Rakaee,
Maria Stensland,
Peder Rustøen Braadland
et al.:
Proteomic analyses identify major vault protein as a prognostic biomarker for fatal prostate cancer
Mehrdad Rakaee,
Thomas Karsten Kilvær,
Simin Jamaly,
Thomas Berg,
Erna-Elise Paulsen,
Marte Berglund
et al.:
Tertiary lymphoid structure score: a promising approach to refine the TNM staging in resected non-small cell lung cancer
British Journal of Cancer 2021
DOI
Maria Jenvin Støen,
Sigve Andersen,
Mehrdad Rakaee,
Mona Irene Pedersen,
Lise Martine Ingebriktsen,
Roy M. Bremnes
et al.:
High expression of miR-17-5p in tumor epithelium is a predictor for poor prognosis for prostate cancer patients
Simin Jamaly,
Mehrdad Rakaee,
Reza Abdi,
George tsokos,
Kristin Andreassen Fenton
:
Interplay of immune and kidney resident cells in the formation of tertiary lymphoid structures in lupus nephritis
Maria Jenvin Støen,
Sigve Andersen,
Mehrdad Rakaee,
Mona I. Pedersen,
Lise Martine Ingebriktsen,
Tom Dønnem
et al.:
Overexpression of mir-20a-5p in tumor epithelium is an independent negative prognostic indicator in prostate cancer—a multi-institutional study
Thomas Karsten Kilvær,
Erna-Elise Paulsen,
Sigve Andersen,
Mehrdad Rakaee,
Roy M. Bremnes,
Lill-Tove Rasmussen Busund
et al.:
Digitally quantified CD8+ cells: the best candidate marker for an immune cell score in non-small cell lung cancer?
Mehrdad Rakaee,
Lill-Tove Busund,
Simin Jamaly,
Erna-Elise Paulsen,
Elin Richardsen,
Sigve Andersen
et al.:
Prognostic Value of Macrophage Phenotypes in Resectable Non–Small Cell Lung Cancer Assessed by Multiplex Immunohistochemistry
Elin Richardsen,
Sigve Andersen,
Christian Melbø-Jørgensen,
Mehrdad Rakaee,
Nora Ness,
Samer Al-Saad
et al.:
MicroRNA 141 is associated to outcome and aggressive tumor characteristics in prostate cancer
Elin Richardsen,
Sigve Andersen,
Samer Al-Saad,
Mehrdad Rakaee,
Yngve Nordby,
Mona Irene Pedersen
et al.:
Low expression of miR-424-3p is highly correlated with clinical failure in prostate cancer
Thomas Karsten Kilvær,
Mehrdad Rakaee,
Turid Hellevik,
Jørg Vik,
Luigi de Petris,
Tom Dønnem
et al.:
Differential prognostic impact of platelet-derived growth factor receptor Expression in NSCLC
Thomas Karsten Kilvær,
Mehrdad Rakaee,
Turid Hellevik,
Arne Östman,
Carina Strell,
Roy M. Bremnes
et al.:
Tissue analyses reveal a potential immune-adjuvant function of FAP-1 positive fibroblasts in non-small cell lung cancer
Sigurd Hald,
Mehrdad Rakaee,
Inigo Zubiavrre Martinez,
Elin Richardsen,
Samer Al-Saad,
Erna Elise Paulsen
et al.:
LAG-3 in Non-Small-cell Lung Cancer: Expression in Primary Tumors and Metastatic Lymph Nodes Is Associated With Improved Survival
Clinical Lung Cancer 2018
DOI
Mehrdad Rakaee,
Thomas Karsten Kilvær,
Stig Manfred Dalen,
Elin Richardsen,
Erna Elise Paulsen,
Sigurd Hald
et al.:
Evaluation of tumor-infiltrating lymphocytes using routine H&E slides predicts patient survival in resected non-small cell lung cancer
Thea K.W. Grindstad,
Elin Richardsen,
Sigve Andersen,
Kaja Konstanse Skjefstad,
Mehrdad Rakaee,
Tom Dønnem
et al.:
Progesterone receptors in prostate cancer: Progesterone receptor B is the isoform associated with disease progression
Nora Ness,
Sigve Andersen,
Mehrdad Rakaee,
Cecilie Nordbakken,
Andrey Yurjevich Valkov,
Erna-Elise Paulsen
et al.:
The prognostic role of immune checkpoint markers programmed cell death protein 1 (PD-1) and programmed death ligand 1 (PD-L1) in a large, multicenter prostate cancer cohort
Elin Richardsen,
Sigve Andersen,
Samer Al-Saad,
Mehrdad Rakaee,
Yngve Nordby,
Mona Irene Pedersen
et al.:
Evaluation of the proliferation marker Ki-67 in a large prostatectomy cohort
Erna-Elise Paulsen,
Thomas Karsten Kilvær,
Mehrdad Rakaee,
Elin Richardsen,
Sigurd Hald,
Sigve Andersen
et al.:
CTLA-4 expression in the non-small cell lung cancer patient tumor microenvironment: diverging prognostic impact in primary tumors and lymph node metastases
Cancer Immunology and Immunotherapy 2017
ARKIV /
DOI
Sigve Andersen,
Elin Richardsen,
Mehrdad Rakaee,
Helena Bertilsson,
Roy M. Bremnes,
Magne Børset
et al.:
Expression of phosphatase of regenerating liver (PRL)-3, is independently associated with biochemical failure, clinical failure and death in prostate cancer
Samer Al-Saad,
Elin Richardsen,
Thomas Karsten Kilvær,
Tom Dønnem,
Sigve Andersen,
Mehrdad Rakaee
et al.:
The impact of MET, IGF-1, IGF1R expression and EGFR mutations on survival of patients with non-small-cell lung cancer
Yngve Nordby,
Elin Richardsen,
Mehrdad Rakaee,
Nora Ness,
Tom Dønnem,
Hitendra R.H. Patel
et al.:
High expression of PDGFR-β in prostate cancer stroma is independently associated with clinical and biochemical prostate cancer recurrence
Roy M. Bremnes,
Lill-Tove Busund,
Thomas Karsten Kilvær,
Sigve Andersen,
Elin Richardsen,
Erna-Elise Paulsen
et al.:
The role of tumor-infiltrating lymphocytes in development, progression, and prognosis of non-small cell lung cancer
Journal of Thoracic Oncology 2016
DOI
Erna-Elise Paulsen,
Thomas Karsten Kilvær,
Mehrdad Rakaee,
Samer Al-Saad,
Sigurd Hald,
Sigve Andersen
et al.:
Assessing PDL-1 and PD-1 in non-small cell lung cancer: a novel immunoscore approach
falah jabar,
Sigve Andersen,
Erna-Elise Paulsen,
Masoud Tafavvoghi,
Elin Helmine Richardsen,
Sissel Gyrid Freim Wahl
et al.:
Integrating Artificial intelligence (AI)-based lymphocytic infiltration assessment in early-stage NSCLC: A sub-study of the TNM-I trial
2024
Mehrdad Rakaee
:
Machine learning and AI in pathology for prediction of response to immunotherapy
2024
Elio Adib,
falah jabar,
Masoud Tafavvoghi,
Amin Nassar,
Lill-Tove Rasmussen Busund,
Tom Dønnem
et al.:
Artificial Intelligence-powered analysis of the tumor immune microenvironment in primary and metastatic colorectal cancer
2024
Mehrdad Rakaee,
Patrick Holmstad
:
Mutational drivers of a dysfunctional local immune response in resected non-small cell lung cancer (NSCLC) patients
UiT Norges arktiske universitet 2023
Scheiner Bernhard,
Alessio Antonio,
Kim Gwangil,
D. Goldin Robert,
A.M. Fulgenzi Claudia,
Balcar Lorenz
et al.:
MACHINE LEARNING-BASED ASSESSMENT OF TUMOUR- INFILTRATING LYMPHOCYTES PREDICTS OUTCOMES IN PATIENTS WITH HEPATOCELLULAR CARCINOMA UNDERGOING ATEZOLIZUMAB AND BEVACIZUMAB TREATMENT
2023
Mehrdad Rakaee,
Siri Kristoffersen
:
Developing a machine learning model for tumor cell quantification in standard histology images of lung cancer
UiT Norges arktiske universitet 2023
Elio Adib,
Mehrdad Rakaee,
Amin Nassar,
Elias Bou Farhat,
Stephen Hodi,
David J. Kwiatkowski
:
Machine learning (ML)-based quantification of tumor-infiltrating lymphocytes (TIL) and clinical outcomes of patients with melanoma treated with immune-checkpoint inhibitors (ICI)
2023
Mehrdad Rakaee
:
Stian har livstruende lungekreft: – Jeg er beviset på at forskning nytter
08. June 2023
Mehrdad Rakaee,
Masoud Tafavvoghi,
Elio Adib,
Biagio Ricciuti,
Joao Alessi,
Alessio Cortellini
et al.:
Artificial intelligence algorithm developed to predict immune checkpoint inhibitors efficacy in non–small-cell lung cancer
2023
Mehrdad Rakaee,
Siri Gulliksen Tømmerbakke
:
Tromsø-forsker med på tre posterpresentasjoner
04. June 2022
Mehrdad Rakaee,
Elio Adib,
Biagio Ricciuti,
Lynette M. Sholl,
Joao V.Alessi,
Alessio Cortellini
et al.:
Digital quantification of lymphocytic infiltration on routine H&E images and immunotherapy response in non-small cell lung cancer
2022
Elio Adib,
Amin Nassar,
Talal El.Zarif,
Neil Kale,
Mehrdad Rakaee,
Tarek H. Mouhieddine
et al.:
Dual CDKN2A/MTAP loss compared to CDKN2A loss alone and response to immunecheckpoint inhibitors (ICI) in advanced solid tumors
2022
Mehrdad Rakaee,
Kiniena Tekie
:
Heterogeneity Assessment of PD-L1 Expression in Biopsy Versus Resected Specimens of Lung Adenocarcinoma - Machine Learning Approach
UiT Norges arktiske universitet 2022
Mehrdad Rakaee
:
Digital quantification of lymphocytic infiltration on routine H&E images predicts efficacy of immunotherapy in NSCLC
2022
Mehrdad Rakaee,
Elio Adib,
Biagio Ricciuti,
Lynette M. Sholl,
Weiwei Shi,
Joao V.Alessi
et al.:
Artificial intelligence in digital pathology approach identifies the predictive impact of tertiary lymphoid structures with immune-checkpoints therapy in NSCLC
2022
Mehrdad Rakaee
:
AI-based in-situ immunophenotypes and genomic alterations in non-small cell lung cancer
2022
Mehrdad Rakaee,
Elio Adib,
Biagio Ricciuti,
Lynette M. Sholl,
Weiwei Shi,
Joao V Alessi
et al.:
Computational pathology by Artificial Intelligence (AI) on quantifying the lymphocytic infiltration predicts the immunotherapy response in NSCLC
2022
Mehrdad Rakaee
:
AI-based pathology predicts immunotherapy response in lung
cancer
2022
Mehrdad Rakaee
:
Genomic and Immunological Landscape of Scandinavian NSCLC
2021
Mehrdad Rakaee
:
Immune Infiltration and Clinical Outcome in Non-Small Cell Lung Cancer
UiT Norges arktiske universitet 2019
Kaja Konstanse Skjefstad,
Thea K.W. Grindstad,
Mehrdad Rakaee,
Elin Richardsen,
Tom Dønnem,
Thomas Karsten Kilvær
et al.:
Corrigendum to "Prognostic relevance of estrogen receptor α, β and aromatase expression in non-small cell lung cancer" [Steroids 113 (2016) 5-13]